BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1
18 results:

  • 1. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
    Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
    J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic cancer.
    Pan P; Qin G; Wang B; Yu H; Chen J; Liu J; Bing K; Shen J; Ren D; Zhao Y; Xia W; Li H; Wu H; Zhou Y
    Cancer Res; 2022 Dec; 82(24):4542-4554. PubMed ID: 36102738
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma.
    Li M; Jiang H; Chen S; Ma Y
    Bioengineered; 2022 Apr; 13(4):11320-11341. PubMed ID: 35491849
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.
    Zhou Q; Yang HJ; Zuo MZ; Tao YL
    J Ovarian Res; 2022 Apr; 15(1):49. PubMed ID: 35488350
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. gata1-induced upregulation of LINC01503 promotes carboplatin resistance in ovarian carcinoma by upregulating PD-L1 via sponging miR-766-5p.
    Li Y; Zhai Y; Chen Y
    J Ovarian Res; 2021 Aug; 14(1):108. PubMed ID: 34425872
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical and sonographic features for the preoperative prediction of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma.
    Zou M; Wang YH; Dong YF; Lai XJ; Li JC
    J Endocrinol Invest; 2020 Oct; 43(10):1511-1517. PubMed ID: 32253729
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Glycofullerenes as non-receptor tyrosine kinase inhibitors- towards better nanotherapeutics for pancreatic cancer treatment.
    Serda M; Malarz K; Mrozek-Wilczkiewicz A; Wojtyniak M; Musioł R; Curley SA
    Sci Rep; 2020 Jan; 10(1):260. PubMed ID: 31937861
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. gata1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway.
    Liu Z; Zhu Y; Li F; Xie Y
    Protoplasma; 2020 May; 257(3):901-910. PubMed ID: 31897811
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Population-based study of the prevalence and management of self-reported high pain scores in patients with non-resected pancreatic adenocarcinoma.
    Tung S; Coburn NG; Davis LE; Mahar AL; Myrehaug S; Zhao H; Earle CC; Nathens A; Hallet J
    Br J Surg; 2019 Nov; 106(12):1666-1675. PubMed ID: 31639208
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.
    Liu D; Zhang XX; Li MC; Cao CH; Wan DY; Xi BX; Tan JH; Wang J; Yang ZY; Feng XX; Ye F; Chen G; Wu P; Xi L; Wang H; Zhou JF; Feng ZH; Ma D; Gao QL
    Nat Commun; 2018 Apr; 9(1):1739. PubMed ID: 29712898
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Protein-protein interaction and SNP analysis in intraductal papillary mucinous neoplasm.
    Jiang P; Zang W; Wang L; Xu Y; Liu Y; Deng SX
    Gene; 2013 Jan; 513(1):219-24. PubMed ID: 23107772
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer.
    Oliveira-Cunha M; Hadfield KD; Siriwardena AK; Newman W
    Pancreas; 2012 Apr; 41(3):428-34. PubMed ID: 22422135
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells.
    Kisfalvi K; Guha S; Rozengurt E
    J Cell Physiol; 2005 Mar; 202(3):880-90. PubMed ID: 15389644
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
    Guha S; Rey O; Rozengurt E
    Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors.
    Marone M; Pierelli L; Mozzetti S; Masciullo V; Bonanno G; Morosetti R; Rutella S; Battaglia A; Rumi C; Mancuso S; Leone G; Giordano A; Scambia G
    Br J Haematol; 2000 Sep; 110(3):654-62. PubMed ID: 10997978
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pattern of malignant tumors observed in a university hospital: a retrospective analysis.
    Malik IA; Khan WA; Khan ZK
    J Pak Med Assoc; 1998 May; 48(5):120-2. PubMed ID: 9813970
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Is there any value in bimanual pelvic examination as a screening test.
    Grover SR; Quinn MA
    Med J Aust; 1995 Apr; 162(8):408-10. PubMed ID: 7746172
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.